In the time of COVID-19: challenges, successes, and lessons learned from studies in cancer patients

By afschroeder • August 26, 2025

Mack PC, Crawford JM, Chang A, Yin A, Klein SL, Shea P, Hirsch FR, Zidar D, Simon V, Gleason C, McBride R, Cordon-Cardo C, VanOudenhove J, Halene S, Lee FE, Mantis N, Kushi LH, Weiskopf D, Merchant A, Reckamp KL, Skarbinski J, Figueiredo JC. In the time of COVID-19: challenges, successes, and lessons learned from studies in cancer patients. J Natl Cancer Inst. 2025 Aug 1;117(8):1547-1556. doi: 10.1093/jnci/djaf073. PMID: 40127178; PMCID: PMC12342778.

Tags: Cedars Sinai DoM, Hematology/Oncology, Publications

Related Posts

Are Urologists and/or Radiation Oncologists Biased when Reporting of Advantages and Disadvantages of Surgery versus Radiation in Consultations for Early-Stage Prostate Cancer?

Friedrich NA, Luu M, Gale R, Chaplin A, Polineni R, Shiang A, Shin D, Freedland SJ, Spiegel B, Ballas LK, Kokorowski P, Daskivich TJ. Are[...]

Charting the translational pathway: ISSCR best practices for the development of PSC-derived therapies

Barry J, Abranches E, Baptista RP, Barry C, Brandsten C, Bruce K, Carpenter MK, Cavagnaro J, Collins L, Csaszar E, Dashnau J, de Villa D,[...]

Diagnostic Performance of F-18 Flurpiridaz in Women: A Sub-study of the Aurora Phase 3 Trial

Horgan SJ, Heller GV, Maddahi J, Bateman TM, Bax JJ, Beanlands RSB, Berman DS, Garcia EV, Somer E, Tamaki N, Thompson D, Udelson JE. Diagnostic[...]